Literature DB >> 16694450

HEMOPHILIA. II. SOME PROPERTIES OF A SUBSTANCE OBTAINED FROM NORMAL HUMAN PLASMA EFFECTIVE IN ACCELERATING THE COAGULATION OF HEMOPHILIC BLOOD.

A J Patek1, F H Taylor.   

Abstract

Entities:  

Year:  1937        PMID： 16694450      PMCID： PMC424851          DOI： 10.1172/JCI100829

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  Studies on the mode of action of vitamin K.

Authors:  H Dam; F Schønheyder; E Tage-Hansen
Journal:  Biochem J       Date:  1936-06       Impact factor: 3.857

2.  HEMOPHILIA. I. THE ABNORMAL COAGULATION OF THE BLOOD AND ITS RELATION TO THE BLOOD PLATELETS.

Authors:  A J Patek; R P Stetson
Journal:  J Clin Invest       Date:  1936-09       Impact factor: 14.808

3.  The coagulation of blood.

Authors:  J Mellanby
Journal:  J Physiol       Date:  1908-12-30       Impact factor: 5.182
  3 in total
  38 in total

1.  Biochemical genetics of blood coagulation.

Authors:  J B GRAHAM
Journal:  Am J Hum Genet       Date:  1956-06       Impact factor: 11.025

2.  Haemophilia and related conditions.

Authors:  R G MACFARLANE
Journal:  Postgrad Med J       Date:  1954-02       Impact factor: 2.401

3.  A simple method of studying the generation of thrombin in recalcified plasma; application in the investigation of haemophilia.

Authors:  W R PITNEY; J V DACIE
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

4.  Blood at 70: its roots in the history of hematology and its birth.

Authors:  Barry S Coller
Journal:  Blood       Date:  2015-12-10       Impact factor: 22.113

5.  Normal and Abnormal Blood Coagulation: A Review.

Authors:  R G Macfarlane
Journal:  J Clin Pathol       Date:  1948-05       Impact factor: 3.411

6.  THE EFFECT OF FOREIGN SURFACES ON BLOOD COAGULATION.

Authors:  E L Lozner; F H Taylor; H Macdonald
Journal:  J Clin Invest       Date:  1942-03       Impact factor: 14.808

7.  THE COAGULATION DEFECT IN HEMOPHILIA: THE EFFECT, IN HEMOPHILIA, OF THE PARENTERAL ADMINISTRATION OF A FRACTION OF THE PLASMA GLOBULINS RICH IN FIBRINOGEN.

Authors:  G R Minot; C S Davidson; J H Lewis; H J Tagnon; F H Taylor
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

8.  THE COAGULATION DEFECT IN HEMOPHILIA: A COMPARISON OF THE PROTEOLYTIC ACTIVITY OF CHLOROFORM PREPARATIONS OF HEMOPHILIC AND NORMAL HUMAN PLASMA.

Authors:  H J Tagnon; C S Davidson; F H Taylor
Journal:  J Clin Invest       Date:  1943-01       Impact factor: 14.808

9.  STUDIES IN BLOOD COAGULATION: THE COAGULATION PROPERTIES OF CERTAIN GLOBULIN FRACTIONS OF NORMAL HUMAN PLASMA IN VITRO.

Authors:  F H Taylor; C S Davidson; H J Tagnon; M A Adams; A H Macdonald; G R Minot
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

Review 10.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.